Bosh sahifaCONCORDBIO • NSE
add
Concord Biotech Ltd
Yopilish kursi
1 518,60 ₹
Kunlik diapazon
1 478,20 ₹ - 1 531,20 ₹
Yillik diapazon
1 327,05 ₹ - 2 664,00 ₹
Bozor kapitalizatsiyasi
155,36 mlrd INR
Oʻrtacha hajm
70,06 ming
Narx/foyda
40,25
Dividend daromadliligi
0,59%
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,44 mlrd | 1,42% |
Joriy xarajat | 806,93 mln | -20,36% |
Sof foyda | 759,21 mln | -2,13% |
Sof foyda marjasi | 31,09 | -3,51% |
Har bir ulushga tushum | 7,26 | -2,02% |
EBITDA | 976,51 mln | -7,52% |
Amaldagi soliq stavkasi | 24,94% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,84 mlrd | 26,07% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 15,90 mlrd | — |
Tarqatilgan aksiyalar | 104,57 mln | — |
Narxi/balansdagi bahosi | 9,99 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 13,28% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 759,21 mln | -2,13% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Tashkil etilgan
2000
Xodimlar soni
1 377
